Helicobacter pylori infection upregulates endothelial nitric oxide synthase expression and induces angiogenesis in gastric mucosa of dyspeptic patients

European Journal of Gastroenterology and Hepatology

Volumn 20, Issue 5, 2008, Pages 441-449

  Lazaraki, Georgia ^a   Kountouras, Jannis ^b   Metallidis, Simeon ^a   Vrettou, Eleni ^c   Tzioufa, Valentini ^c   Germanidis, Georgios ^a   Chatzopoulos, Dimitrios ^b   Zavos, Christos ^b   Giannoulis, Kleanthis ^a   Nikolaidis, Paul ^a  

^a AHEPA UNIVERSITY HOSPITAL   (Greece)

^b Ippokration Hospital   (Greece)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Angiogenesis; Endothelial NOS; Gastric mucosa; Helicobacter pylori; Nitric oxide

Indexed keywords

CD34 ANTIGEN; ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ADULT; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DYSPEPSIA; FEMALE; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MICROVASCULATURE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; STOMACH ANTRUM; STOMACH MUCOSA; UPREGULATION;

ADULT; AGED; ANTIGENS, CD34; DYSPEPSIA; FEMALE; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE SYNTHASE TYPE III; PROSPECTIVE STUDIES; UP-REGULATION;

EID: 42149141783     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3282f4c35a     Document Type: Article

References (61)

1. Nathan C. Inducible nitric oxide synthase: what difference dose it make? J Clin Invest 1997; 100:2417-2423.
2. Catalayud S, Barrachina D, Esplugues JV. Nitric oxide: relation to integrity, injury, and healing of the gastric mucosa. Micrsc Res Tech 2001; 53:325-335.
3. Ma L, Wallace JL. Endothelial nitric oxide synthase modulates gastric ulcer healing in rats. Am J Physiol 2000; 279:G341-G346.
4. Masuda E, Kawano S, Nagano K, Tsuji S, Takei Y, Tsujii M, et al. Endogenous nitric oxide modulates ethanol-induced gastric mucosal injury in rats. Gastroenterology 1995; 108:58-64.
5. Colasanti M, Suzuki H. The dual personality of NO. Trends Pharmacol Sci 2002; 21:249-252.
6. Guo JS, Cho CH, Wang JY, Koo MW. Differential effects of selective and non-selective inhibition of nitric oxide synthase on the expression and activity of cyclooxygenase-2 during gastric ulcer healing. Eur J Pharmacol 2006; 536:301-307.
7. (2+)-independent nitric oxide synthases. FEBS Lett 1991; 291:145-149.
8. Whittle BJ, Laszlo F, Evans SM, Moncada S. Induction of nitric oxide synthase and microvascular injury in the rat jejunum provoked by indomethacin. Br J Pharmacol 1995; 116:2286-2290.
9. Lopez-Belmonte J, Whittle BJ, Moncada S. The actions of nitric oxide donors in the prevention or induction of injury to the rat gastric mucosa. Br J Pharmacol 1993; 108:73-78.
10. Lamarque D, Whittle BJ. Involvement of superoxide and xanthine oxidase in neutrophil-independent rat gastric damage induced by NO donors. Br J Pharmacol 1995; 116:1843-1848.
11. Chaturvedi R, Asim M, Lewis ND, Algood HM, Cover TL, Kim PY, et al. L-arginine availability regulates inducible nitric oxide synthase-dependent host defense against Helicobacter pylori. Infect Immun 2007; 75:4305-4315.
12. Chang CS, Chen WN, Lin HH, Wu CC, Wang CJ. Increased oxidative DNA damage, inducible nitric oxide synthase, nuclear factor kappaB expression and enhanced antiapoptosis-related proteins in Helicobacter pylori-infected non-cardiac gastric adenocarcinoma. World J Gastroenterol 2004; 10:2232-2240.
13. Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, et al. Roles of nitric oxide in tumor growth. Proc Natl Acad Sci U S A 1995; 92:4392-4396.
14. Yamagushi T, Kamada K, Dayton C, Gaskin FS, Yusof M, Yoshikawa T, et al. Role of eNOS-derived NO in the postischemic anti-inflammatory effects of antecedent ethanol ingestion in murine small intestine. Am J Physiol Heart Circ Physiol 2007; 292:H1435-H1442.
15. Kountouras J, Deretzi G, Zavos C, Karatzoglou P, Touloumis L, Nikolaidis T, et al. Association between Helicobacter pylori infection and acute inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol 2005; 12:139-143.
16. Weinstein WM. Gastritis and gastropathies. In: Sleisenger MH, Fordtran JS, editors. Gastrointestinal disease: pathology, diagnosis, management. 5th ed. Philadelphia: Saunders; 1993. pp. 545-571.
17. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis, the updated Sydney system. Am J Surg Pathol 1996; 20:1161-1181.
18. Nardone G, Rocco A, Vaira D, Staibano S, Budillon A, Tatangelo F, et al. Expression of COPX-2, mPGE-synthase 1, MDR-1(P-gp), and Bcl-xL: a molecular pathway of H. pylori-related gastric carcinogenesis. J Pathol 2004; 202:305-312.
19. 2-dependent nitric oxide synthase activity in human astrocytoma cells. J Biol Chem 1997; 272:7582-7585.
20. Doi C, Noguchi Y, Marat D, Saito A, Fukuzawa K, Yoshikawa T, et al. Expression of nitric oxide synthase in gastric cancer. Cancer Lett 1999; 144:161-167.
21. Yeo M, Kim DK, Han SU, Saito A, Fukuzawa K, Yoshikawa T, et al. Novel action of gastric proton pump inhibitor on suppression of Helicobacter pylori induced angiogenesis. Gut 2006; 55:26-33.
22. Tuccilo C, Cuomo A, Rocco A, Martinelli E, Staibano S, Mascolo M, et al. Vascular endothelial growth factor and neo-angiogenesis in H. pylori gastritis in humans. J Pathol 2005; 207:277-284.
23. Wang L, Shi GG, Yao JC, Gong W, Wei D, Wu TT, et al. Expression of endothelial nitric oxide synthase correlates with the angiogenic phenotype of and predicts poor prognosis in human gastric cancer. Gastric Cancer 2005; 8:18-28.
24. Berg A, Kechagias S, Sjostrand SE, Ericson AC. Morphological support for paracrine inhibition of gastric acid secretion by nitric oxide in humans. Scand J Gastroenterol 2001; 36:1016-1021.
25. Bordi C, D'Adda T, Azzoni C, Ferraro G. Classification of gastric endocrine cells at the light and electron microscopical levels. Microsc Res Tech 2000; 48:258-271.
26. Fulton D, Gratton JP, Sessa WC. Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough? J Pharmacol Exp Ther 2001; 299:818-824.
27. Cirino G, Fiorrucci S, Sessa W. Endothelial nitric oxide synthase: the Cinderella of inflammation? Trends Pharmacol Sci 2003; 24:91-95.
28. Papapetropoulos A, Garcia-Cardena G, Madri JA, Sessa W. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 1997; 100:3131-3339.
29. Simoncini T, Varone G, Fornari L, Mannella P, Luisi M, Labrie F, et al. Genomic and nongenomic mechanisms of nitric oxide synthesis induction in endothelial cells by a fourth generation selective estrogen modulator. Endocrinology 2002; 143:2052-2061.
30. Sessa WC, Pritchard K, Seyedi N, Wang J, Hintze TH. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ Res 1994; 74:349-353.
31. Davis ME, Cai H, Drummond GR, Harrison DG. Shear stress regulates endothelial nitric oxide synthase expression through cSrc by divergent signaling pathways. Circ Res 2001; 89:1073-1080.
32. De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MA Jr, et al. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995; 96:60-68.
33. Oshima T, Jordan P, Grisham MB, Alexander JS, Jennings M, Sasaki M, et al. TNF-alpha induced endothelial MAdCAM-1 expression is regulated by exogenous, not endogenous nitric oxide. BMC Gastroenterol 2001; 1:5.
34. Cox JM, Clayton CL, Tomita T, Wallace DM, Robinson PA, Crabtree JE. cDNA array analysis of cag pathogenicity island-associated Helicobacter pylori epithelial cell response genes. Infect Immun 2001; 69:6970-6980.
35. Strowski MZ, Cramer T, Schafer G, Juttner S, Walduck A, Schipani E, et al. Helicobacter pylori stimulates host vascular endothelial growth factor-A (vegf-A) gene expression via MEK/ERK-dependent activation of Sp1 and Sp3. FASEB J 2004; 18:218-220.
36. Caputo R, Tuccillo C, Manzo BA, Zarrilli R, Tortora G, Blanco Cdel V, et al. Helicobacter pylori VacA toxin up-regulates vascular endothelial growth factor expression in MKN 28 gastric cells through an epidermal growth factor receptor-, cyclooxygenase-2-dependent mechanism. Clin Cancer Res 2003; 9:2015-2021.
37. Park JH, Kim TY, Jong HS, Kim TY, Chun YS, Park JW, et al. Gastric epithelial reactive oxygen species prevent normoxic degradation of hypoxiainducible factor-1alpha in gastric cancer cells. Clin Cancer Res 2003; 9:433-440.
38. Innocenti M, Thoreson AC, Ferrero RL, Stromberg E, Bolin I, Eriksson L, et al. Helicobacter pylori-induced activation of human endothelial cells. Infect Immun 2002; 70:4581-4590.
39. Yeo M, Kim DK, Kim YB, Oh TY, Lee JE, Cho SW, et al. Selective induction of apoptosis with proton pump inhibitor in gastric cancer cells. Clin Cancer Res 2004; 10:8687-8696.
40. Langston W, Childlow JH, Booth BH, Barlow SC, Lefer DJ, Patel RP, et al. Regulation of endothelial glutathione by ICAM-1 governs VEGF-A-mediated eNOS activity and angiogenesis. Free Rad Biol Med 2007; 42:720-729.
41. Yasoui W, Oue N, Aung PP, Matsumura S, Shutoh M, Nakayama H. Molecular-pathological prognostic factors of gastric cancer: a review. Gastric Cancer 2005; 8:86-94.
42. Kitadai Y, Sasaki A, Ito M, Oue N, Yasui W, Aihara M, et al. Helicobacter pylori infection influences expression of genes related to angiogenesis and invasion in human gastric carcinoma cells. Biochem Biophys Res Commun 2003; 311:809-814.
43. Han HS, Hwang TS. Angiogenesis in gastric cancer: importance of the thymidine phosphorylase expression of cancer cells as an angiogenic factor. Oncol Rep 2007; 17:61-65.
44. Alderton WK, Cooper CE, Knowles G. Nitric oxide synthases: structure, function and inhibition. Biochem J 2001; 357:593-615.
45. Garcia-Cardena G, Fan R, Shah V, Sorrentino R, Cirino G, Papapetropoulos A, et al. Dynamic activation of endothelial nitric oxide synthase by HSP90. Nature 1998; 392:821-824.
46. Gratton JP, Fontan J, O'Connor DS, Garcia-Cardena G, McCabe TJ, Sessa WC. Reconstitution of an endothelial nitric oxide synthase (eNOS), HSP90, and caveolin-1 complex in vitro. Evidence that HSP90 facilitates calmodulin-stimulated displacement of eNOS from caveolin-1. J Biol Chem 2000; 275:22268-22272.
47. Russell KS, Haynes MP, Caulin-Glasser T, Rosneck J, Sessa WC, Bender JR. Estrogen stimulates heat shock protein 90 binding to endothelial nitric oxide synthase in human vascular endothelial cells. Effect on calcium sensitivity and NO release. J Biol Chem 2000; 275:5026-5030.
48. Gallis B, Corthals GL, Goodlett DR, Ueba H, Kim F, Presnell SR, et al. Identification of flow dependent endothelial nitric-oxide synthase phosphorylation sites by mass spectrometry and regulation of phosphorylation and nitric oxide production by the phosphatidylinositol 3-kinase inhibitor LY294002. J Biol Chem 1999; 274:30101-30108.
49. 2+-dependent to the late phosphorylationdependent activation of the endothelial nitric-oxide synthase in vascular endothelial growth factor-exposed endothelial cells. J Biol Chem 2001; 276:32663-32669.
50. Fontana J, Fulton D, Chen Y, Fairchild TA, McCabe TJ, Fujita N, et al. Domain mapping studies reveal that the M domain of HSP90 serves as a molecular scaffold to regulate Akt-dependent phosphorylation of endothelial nitric oxide synthase an NO release. Circ Res 2002; 90:866-873.
51. Ang KL, Shi DL, Keong WW, Epstein RJ. Upregulated Akt signaling adjacent to gastric cancers: implications for screening and chemoprevention. Cancer Lett 2005; 225:53-59.
52. Ashktorab H, Daremipouran M, Wilson M, Siddiqi S, Lee EL, Rakhshani N, et al. Transactivation of the EGFR by AP-1 is induced by Helicobacter pylori in gastric cancer. Am J Gastroenterol 2007; doi:10.1111/j.1572-0241.2007.01400.x [Epub ahead of print].
53. Liu Z, Ziang Y, Hao H, Gupta K, Xu J, Chu L, et al. Endothelial nitric oxide synthase is dynamically expressed during bone marrow stem cell differentiation into endothelial cells. Am J Physiol Heart Circ Physiol 2007; doi: 10.1152/ajpheart.01408.2006 [Epub ahead of print].
54. Houghton J, Stoicov C, Nomura S, Rogers AB, Carlson J, Li H, et al. Gastric cancer originating from bone marrow-derived cells. Science 2004; 306:1568-1571.
55. Kountouras J, Zavos C, Chatzopoulos D, Katsinelos P. New Aspects of Helicobacter pylori infection involvement in gastric oncogenesis. J Surg Res 2007; [Epub ahead of print].
56. Brzozowski T, Konturek PC, Konturek SJ, Shuppan D, Drozdovic D, Kwiecien S, et al. Effect of local application of growth factors on gastric ulcer healing and mucosal expression of cyclooxygenase-1 and -2. Digestion 2001; 64:15-29.
57. Barnard JA, Beauchamp RD, Russell WE, DuBois RN, Coffey RJ. Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology. Gastroenterology 1995; 108:564-580.
58. Jordan MA, Wilson L. Microtubules as a target for anticancer drugs. Nat Rev Cancer 2004; 4:253-265.
59. Von Bothmer C, Edebo A, Lonroth H, Olbe L, Pettersson A, Fandriks L. Helicobacter pylori infection inhibits antral mucosal nitric oxide production in humans. Scand J Gastroenterol 2002; 37:404-408.
60. Tarnawski A. Cellular and molecular mechanisms of gastrointestinal ulcer healing. Dig Dis Sci 2005; 50:S24-S33.
61. Lee E, Feldman M. Gastritis and gastropathies. In: Feldman M, Friedman LS, Sleisenger MH, editors. Sleisenger & Fordtran's gastrointestinal disease: pathology, diagnosis, management, 7th ed. Philadelphia: Saunders; 2002. pp. 810-827.